World Health Organization Executive Board to create new consultative expert working group on R&D FinancingSubmitted by James Love on 17. January 2011 - 8:55
Today the WHO is expected to take up the Report by the Secretariat on "the Establishment of a consultative expert working group on research and development: financing and coordination." (link here).
European Commission (DG 1) note on the WHO's Revised Drug Stategy
DIRECTORATE GENERAL 1
EXTERNAL RELATIONS: COMMERCIAL POLICY AND RELATIONS WITH NORTH AMERICA. THE
FAR EAST, AUSTRALIA AND NEW ZEALAND
Directorate D -Sectoral trade questions, market access
New technologies, Intellectual property, public procurement
Brussels, 5 October 1998
1/D/3/BW D (98)
The following are selected documents from the 1998 to 1999 WHO debate of the revised drug strategy.
- The January 1998 proposal for the Revised Drug Strategy (EB101.R24)
- May 27, 1998 Department of State cable: Revised Drug Strategy At W.H.O.: Atmospherics Of The Debate, And Recommended Plan Of Action.
- European Commission October 5, 1998 memorandum on the WHO Revised Drug Strategy negotiation
A pdf copy of the resolution is attached to this page.
THE FIFTY-SECOND WORLD HEALTH ASSEMBLY
Agenda Item 13
May 24, 1999
Revised Drug Strategy
The Fifty-second World Health Assembly,
Recalling resolution WHA39.27, WHA41.16, WHA43.20, WHA45.27, WHA47.12, WHA47.13, WHA47.16, WHA47.17, and WHA49.14;
Having considered the report of the Director-General on the revised drug strategy;
May 27, 1998 Department of State cable: REVISED DRUG STRATEGY AT W.H.O.: ATMOSPHERICS OF THE DEBATE, AND RECOMMENDED PLAN OF ACTIONSubmitted by James Love on 23. August 2010 - 14:37
CONFIDENTIAL RELEASED IN FULL
PAGE 01 GENEVA 03470 01 OF 09 271621Z ACTION 10-00
425261 271705Z /38 O 271615Z MAY 98
FM USMISSION GENEVA
TO SECSTATE WASHDC IMMEDIATE 6208 INFO IO COLLECTIVE AMEMBASSY LONDON
AMEMBASSY BUENOS AIRES AMEMBASSY PRETORIA AMEMBASSY HARARE
AMEMBASSY LILONGWE AMEMBASSY LUSAKA
AMEMBASSY WINDHOEK AMEMBASSY BERN
AMEMBASSY STOCKHOLM AMEMBASSY TOKYO AMEMBASSY OSLO
AMEMBASSY BRUSSELS AMEMBASSY BONN
AMEMBASSY OTTAWA AMEMBASSY CAIRO CDC ATLANTA
WHO releases names of experts and advisor to the Emergency Committee concerning Influenza Pandemic (H1N1) 2009Submitted by thiru on 11. August 2010 - 2:09
WHO has released the 'List of Members of, and Advisor to, the International Health Regulations (2005) Emergency Committee concerning Influenza Pandemic (H1N1) 2009' at the following site: http://www.who.int/ihr/emerg_comm_members_2009/en/. Of the 15 members and one advisor, 6 had declaration of interests. On this matter, WHO had the following statement:
Anne Marie Worning appointed as new acting head of WHO's team on public health, innovation and intellectual propertySubmitted by thiru on 4. June 2010 - 9:19
On 4 June 2010, Dr. Margaret Chan (Director General, World Health Organization) announced Dr. Anne Marie Worning as 'acting Director, Public Health, Innovation and Intellectual Property (PHI)'. According to the WHO website,
Dr Anne Marie Worning, a Danish national, is the Executive Director of the Director-General's Office since April 2009.
On 19 May 2010, Global Health Progress (GHP) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) hosted a luncheon at the Vieux Bois in Geneva on the margins of the 63rd World Health Assembly for a targeted audience of over 90 persons including Ministers of Health, Ambassadors and senior officials from the Africa.
SAVE THE DATE: 19 May 2010-Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicinesSubmitted by thiru on 18. May 2010 - 11:05
Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines
Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty
Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30